Abstract

As attitudes toward cannabis, its legal status, and patterns of use continue to evolve, the landscape surrounding this substance is in a constant state of flux. Against this backdrop, this review aims to provide an up-to-date overview of the literature on the comorbidity of cannabis use and cannabis use disorder (CUD) with other substance use and psychiatric disorders.

Results: 

• A strong body of literature shows associations between cannabis use and CUD with other drug use, psychosis, mood disorders, anxiety disorders, and personality disorders.
• The strongest evidence of a...

Introdução 

Há crescente interesse e evidências para o uso de medicamentos canabinoides no tratamento do transtorno por uso de cannabis, mas pouco exame dos correlatos do tratamento bem-sucedido. Este artigo é uma análise secundária de um ensaio clínico randomizado controlado por placebo de nabiximols para o tratamento do transtorno do uso de cannabis (CUD), com o objetivo de identificar quais características do cliente e do tratamento afetam o engajamento e os resultados do tratamento.

Método

Modelos de regressão múltipla bayesiana foram usados para examinar o impacto da idade, sexo...

Introduction and aims

There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (CUD), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes.

Method

Bayesian multiple regression models were used to examine the impact of age, gender, duration of regular cannabis use, daily quantity...